Personal trainers who view weight loss medications as shortcuts that undermine fitness efforts
His story reflects the importance of consistent access to treatment
Free UK shipping on orders 150+Flash Sale: flat 20% off.New customer
Last reviewed: July 11, 2026 Last updated: July 11, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Despite these impressive results, semaglutide does not function as a localized bellyfat eraser
Government-backed Medicare plans for adults aged 65 and older and those with disabilities are barred from covering weight-loss treatments, though the Biden administration has proposed to expand the coverage of anti-obesity drugs